GB202117798D0 - Antibodies for the prevention and treatment of corona virus caused diseases - Google Patents

Antibodies for the prevention and treatment of corona virus caused diseases

Info

Publication number
GB202117798D0
GB202117798D0 GBGB2117798.5A GB202117798A GB202117798D0 GB 202117798 D0 GB202117798 D0 GB 202117798D0 GB 202117798 A GB202117798 A GB 202117798A GB 202117798 D0 GB202117798 D0 GB 202117798D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
prevention
treatment
corona virus
caused diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2117798.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norimun As
Original Assignee
Norimun As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norimun As filed Critical Norimun As
Priority to GBGB2117798.5A priority Critical patent/GB202117798D0/en
Publication of GB202117798D0 publication Critical patent/GB202117798D0/en
Ceased legal-status Critical Current

Links

GBGB2117798.5A 2021-12-09 2021-12-09 Antibodies for the prevention and treatment of corona virus caused diseases Ceased GB202117798D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2117798.5A GB202117798D0 (en) 2021-12-09 2021-12-09 Antibodies for the prevention and treatment of corona virus caused diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2117798.5A GB202117798D0 (en) 2021-12-09 2021-12-09 Antibodies for the prevention and treatment of corona virus caused diseases

Publications (1)

Publication Number Publication Date
GB202117798D0 true GB202117798D0 (en) 2022-01-26

Family

ID=80080214

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2117798.5A Ceased GB202117798D0 (en) 2021-12-09 2021-12-09 Antibodies for the prevention and treatment of corona virus caused diseases

Country Status (1)

Country Link
GB (1) GB202117798D0 (en)

Similar Documents

Publication Publication Date Title
IL275777A (en) Improved peptide pharmaceuticals for treatment of nash and other disorders
IL288214A (en) Quinazolin-4-one derivatives useful for the treatment of braf-associated diseases and disorders
IL286636A (en) Compositions and methods for the treatment of kras associated diseases or disorders
IL288375A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP4009948A4 (en) Use of tgf-alpha polypeptide or anti-tgf-alpha antibodies for the treatment of diseases and disorders
IL287796A (en) Compositions and methods for the treatment of atpase-mediated diseases
ZA202006234B (en) Compositions and methods for the treatment of neurological diseases
IL280315A (en) Methods of treatment and prevention of alzheimer's disease
IL290792A (en) Compositions and methods for the treatment of viral infections
IL279397A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL288220A (en) Antibodies against disease causing agents of poultry and uses thereof
GB201907558D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP4054713A4 (en) Compositions and methods for treatment or prevention of skin diseases and disorders with lekti
GB202020502D0 (en) Antibody composistion for treatment of corona virus infection
EP3960858A4 (en) Small rna medicament for prevention and treatment of inflammation-related diseases and combination thereof
IL275714A (en) A combination of plasma immunoglobulin and antigen- specific immunoglobulin for the modification of the immune system and the treatment or prevention of allergic diseases
EP3955914A4 (en) Novel compounds and methods of use treating fructose-related disorders or diseases
GB202117798D0 (en) Antibodies for the prevention and treatment of corona virus caused diseases
IL286415A (en) Monoclonal antibodies for prevention and treatment of herpes simplex viral infections
IL285751A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL286836A (en) Combinations of transcription inhibitors and immune checkpoint inhibitors for treatment of disease
EP3917619A4 (en) Structurally modified opioids for prevention and treatment of diseases and conditions
KR102523841B9 (en) -19- An integrated quarantine system for the establishment of Corona Virus Disease-19-freezone via photo-bactericidal treatment and related systems using the same
EP3732204A4 (en) Anti-renalase antibodies for the treatment and prevention of diseases and disorders
IL308042A (en) Antibodies for the treatment and prevention of covid-19 and emerging variants

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)